Universal-Beteiligungs- und Servicegesellschaft’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
47,278
-315
-0.7% -$56.1K 0.02% 627
2026
Q1
$8.24M Sell
47,593
-1,248
-3% -$231K 0.01% 677
2025
Q4
$9.77M Buy
48,841
+3,183
+7% +$577K 0.02% 623
2025
Q3
$7.14M Buy
45,658
+27,681
+154% +$4.4M 0.01% 721
2025
Q2
$2.73M Buy
17,977
+6,558
+57% +$875K ﹤0.01% 1068
2025
Q1
$1.72M Sell
11,419
-7,991
-41% -$1.34M ﹤0.01% 1272
2024
Q4
$3.58M Buy
+19,410
New +$3.74M 0.01% 789

Other funds holding CRL

Universal-Beteiligungs- und Servicegesellschaft's CRL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Charles River Laboratories (CRL) stake by 0.66% in Q2 2026, selling an estimated $56.1K and leaving 47,278 shares worth $10.7M. The position accounts for 0.02% of the portfolio, ranked #627.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 47,278 shares of Charles River Laboratories worth $10.7M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 315 Charles River Laboratories shares in Q2 2026, an estimated $56.1K.
  • Charles River Laboratories made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #627 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.